In a highly influential SNQ National Quality Mark evaluation, SunWay Biotech’s flagship product, ANKASCIN® 568-R red yeast extract, has emerged as the sole recipient of the Bronze Award in the Nutrition and Special Functional Health Ingredients category. This prestigious accolade, which also places ANKASCIN® 568-R as the top-ranking product in the entire category, was received by President John Pan on behalf of SunWay Biotech. It signifies the government, industry, and academia’s recognition of the company’s outstanding innovation and product quality in the field of health foods. ANKASCIN® 568-R is a groundbreaking red yeast supplement material known for its unique red yeast extract that does not contain Monacolin K. It boasts a rich content of Monascin and Ankaflavin, both of which have been scientifically proven to offer significant health benefits, including anti-glycation, antioxidant, and anti-inflammatory properties. Furthermore, ANKASCIN® 568-R has successfully passed rigorous scientific research and clinical trials, earning certification from the United States FDA as a New Dietary Ingredient (NDI). This achievement further substantiates its safety and efficacy as a leading health ingredient. The SNQ National Quality Mark is a highly authoritative award that symbolizes “Safety and Quality,” aiming to recognize exceptional achievements in products that promote healthy and high-quality living. This evaluation brought together a panel of 160 experts from the industry, government, and academia, who selected 16 outstanding […]

During 14-16 March 2021, 4th World Congress and Expo on Traditional and Alternative Medicine is organized in collaboration with Taipei Chinese Medical Association, Meridian World Health Organization Alliance (MWHOA), Chang Gung University, Tzu Chi University, I Shou University, and China Medical University. The Congress focused on the theme “World Health for everyone with local Wisdom and Resources,” with the domestic well-known speakers and international scholars were invited to publish the research of traditional and alternative medical therapies for global health issues through this online conference. The Head of Technology of SunWay Biotech, Dr. Tzu-Ming Pan, was invited as a speaker by Taipei Chinese Medical Association and Global Scientific Guild to announce at the conference that heart health supplement plays an important role for global health. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally. WHO says that about 17.9 million people worldwide died from CVDs in 2016 alone, representing 31 percent of all global deaths. Moreover, amid the COVID-19 crisis, the global market for Heart Healthy Ingredients estimated at US$16.6 Billion in the year 2020, is projected to reach a revised size of US$24.8 Billion by 2027, growing at a of 5.9% over the analysis period 2020-2027. Red yeast rice, as a dietary supplement ingredient for heart health, is prized for its ability to lower cholesterol […]

  “The superior effects of MS and AK in ANKASCIN® 568-R show significant results, from managing glycation and inflammation to improving hyperglycemia, hyperlipidemia, hypertension, and cognitive health. This novel ingredient is clinically proven, safe, has multiple applications in dietary supplements and functional food, is compliant with EU and US regulations, and provides excellent support for healthy aging.”   According to the WHO, around one in ten people in Europe or US has diabetes, which means that if you go out with your relatives, there’s a good chance that the person you’re arm-in-arm with is someone who has diabetes. Chronic diabetic complications, including hyperlipidemia, hypertension, or Alzheimer’s disease, have been related to advanced glycation end product (AGE) accumulation. Glycation and AGEs lead to accelerated organ aging, thus causing the vicious cycle of tissue glycation and aging. However, the Western diet, which is full of AGEs, and COVID-19 have aggravated this already grim scenario. Reports show that patients with hyperglycemia and COVID-19 have a 2-to-4-fold risk of severe COVID-19 or death than those without diabetes. ANKASCIN® 568-R is a state-of-the-art ingredient containing high MS and AK levels. It addresses the root cause, mainly via PPARγ/Nrf2 pathways, to manage anti-glycation, antioxidant, and anti-inflammation and acts synergistically in improving the impairment of pancreatic β-cell function (blood glucose regulation), resolving lipid plaque accumulation in the blood […]